Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 1987-1991, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J. T.
Right arrow Articles by Wilson, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J. T.
Right arrow Articles by Wilson, L. W.

Clinical Chemistry, Vol 34, 1987-1991, Copyright © 1988 by American Association for Clinical Chemistry

Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay

JT Wu and LW Wilson
Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132.

We evaluated and compared Abbott Laboratories' newly developed enzyme immunoassay (EIA) for measuring progesterone receptors (PgR) with that of DuPont's steroid-binding assay (SBA). We also used both methods to study the stability of PgR under various conditions. THere were excellent correlations for all 59 cytosols compared (r = 0.94) and for the 44 cytosols containing PgR greater than 10 fmol per milligram of protein (r = 0.93), but the correlation for cytosols containing less than 10 fmol of PgR per milligram was poor. We found PgR to be more stable as assayed by EIA than by SBA. The biological half-lives of PgR at 30, 4, and -60 degrees C were approximately 3 h, 6 days, and 19 days, respectively. The effect of molybdate on PgR is complex. Its presence during tissue homogenization leads to analytical recovery of more PgR and may stabilize PgR during storage. Its presence during enzyme immunoassay is less critical. Unlike estrogen receptor, PgR is not protected by its ligand, R5020.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.